Overview

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Status:
Completed

Trial end date:
2004-07-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the safety and efficacy of dose conversion from hydrocodone/ acetaminophen (Vicodin®) to the buprenorphine transdermal system (Butrans™) in subjects with osteoarthritis pain of the hip or knee. The double-blind treatment intervention duration is 2 weeks during which time supplemental analgesic medication will be allowed.

Phase:

Phase 3

Details

Lead Sponsor:

Purdue Pharma LP

Treatments:

Acetaminophen, hydrocodone drug combination
Buprenorphine